Clinical Trials Browser

Phase 1 × Interventional × monoclonal antibody YYB-101 × Clear all

NCT02499224 2021-05-13

Safety and Pharmacokinetics Study of YYB101 in Advanced Solid Tumors Patients Who Are Refractory to Standard Therapy

Phase 1 Completed

Other solid neoplasm

Solid Tumors